nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—CYP3A5—prostate cancer	0.133	0.698	CbGaD
Mycophenolate mofetil—CYP3A4—prostate cancer	0.0578	0.302	CbGaD
Mycophenolate mofetil—CES1—Capecitabine—prostate cancer	0.0355	0.0749	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Cabazitaxel—prostate cancer	0.0283	0.0597	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0181	0.0381	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Cabazitaxel—prostate cancer	0.0165	0.0347	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Estrone—prostate cancer	0.0161	0.034	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Estradiol—prostate cancer	0.0159	0.0335	CbGbCtD
Mycophenolate mofetil—UGT1A1—Estradiol—prostate cancer	0.0134	0.0282	CbGbCtD
Mycophenolate mofetil—ABCG2—Cabazitaxel—prostate cancer	0.0131	0.0276	CbGbCtD
Mycophenolate mofetil—UGT2B7—Epirubicin—prostate cancer	0.013	0.0273	CbGbCtD
Mycophenolate mofetil—ABCG2—Estrone—prostate cancer	0.0128	0.027	CbGbCtD
Mycophenolate mofetil—ABCC2—Ethinyl Estradiol—prostate cancer	0.0126	0.0266	CbGbCtD
Mycophenolate mofetil—ALB—Abiraterone—prostate cancer	0.0122	0.0257	CbGbCtD
Mycophenolate mofetil—CYP2C8—Nilutamide—prostate cancer	0.0114	0.024	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0105	0.0222	CbGbCtD
Mycophenolate mofetil—CYP3A5—Flutamide—prostate cancer	0.00981	0.0207	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Docetaxel—prostate cancer	0.0095	0.02	CbGbCtD
Mycophenolate mofetil—CYP2C8—Abiraterone—prostate cancer	0.00943	0.0199	CbGbCtD
Mycophenolate mofetil—ABCC2—Conjugated Estrogens—prostate cancer	0.00927	0.0195	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Estradiol—prostate cancer	0.00926	0.0195	CbGbCtD
Mycophenolate mofetil—ALB—Estrone—prostate cancer	0.00883	0.0186	CbGbCtD
Mycophenolate mofetil—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00879	0.0185	CbGbCtD
Mycophenolate mofetil—UGT1A1—Etoposide—prostate cancer	0.00873	0.0184	CbGbCtD
Mycophenolate mofetil—ABCG2—Conjugated Estrogens—prostate cancer	0.00838	0.0176	CbGbCtD
Mycophenolate mofetil—ABCG2—Mitoxantrone—prostate cancer	0.00761	0.016	CbGbCtD
Mycophenolate mofetil—ABCG2—Estradiol—prostate cancer	0.00735	0.0155	CbGbCtD
Mycophenolate mofetil—CYP3A5—Cabazitaxel—prostate cancer	0.00726	0.0153	CbGbCtD
Mycophenolate mofetil—ABCB1—Estramustine—prostate cancer	0.00716	0.0151	CbGbCtD
Mycophenolate mofetil—CYP3A5—Estrone—prostate cancer	0.00709	0.0149	CbGbCtD
Mycophenolate mofetil—CYP2C8—Cabazitaxel—prostate cancer	0.00698	0.0147	CbGbCtD
Mycophenolate mofetil—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00608	0.0128	CbGbCtD
Mycophenolate mofetil—ABCC2—Etoposide—prostate cancer	0.00531	0.0112	CbGbCtD
Mycophenolate mofetil—ALB—Estradiol—prostate cancer	0.00507	0.0107	CbGbCtD
Mycophenolate mofetil—ABCC2—Docetaxel—prostate cancer	0.00486	0.0102	CbGbCtD
Mycophenolate mofetil—ABCG2—Etoposide—prostate cancer	0.0048	0.0101	CbGbCtD
Mycophenolate mofetil—ABCB1—Cabazitaxel—prostate cancer	0.00472	0.00995	CbGbCtD
Mycophenolate mofetil—CYP3A4—Bicalutamide—prostate cancer	0.00462	0.00973	CbGbCtD
Mycophenolate mofetil—ABCB1—Estrone—prostate cancer	0.00462	0.00973	CbGbCtD
Mycophenolate mofetil—ABCG2—Docetaxel—prostate cancer	0.00439	0.00926	CbGbCtD
Mycophenolate mofetil—ALB—Prednisone—prostate cancer	0.00436	0.00918	CbGbCtD
Mycophenolate mofetil—CYP3A4—Estramustine—prostate cancer	0.00429	0.00904	CbGbCtD
Mycophenolate mofetil—ABCB1—Ethinyl Estradiol—prostate cancer	0.00412	0.00867	CbGbCtD
Mycophenolate mofetil—CYP3A5—Estradiol—prostate cancer	0.00407	0.00858	CbGbCtD
Mycophenolate mofetil—CYP2C8—Estradiol—prostate cancer	0.00392	0.00825	CbGbCtD
Mycophenolate mofetil—CYP3A4—Flutamide—prostate cancer	0.00383	0.00806	CbGbCtD
Mycophenolate mofetil—CYP3A4—Abiraterone—prostate cancer	0.00383	0.00806	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—prostate cancer	0.00362	0.00763	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—prostate cancer	0.00328	0.0069	CbGbCtD
Mycophenolate mofetil—ABCB1—Conjugated Estrogens—prostate cancer	0.00302	0.00636	CbGbCtD
Mycophenolate mofetil—CYP3A4—Cabazitaxel—prostate cancer	0.00283	0.00596	CbGbCtD
Mycophenolate mofetil—UGT1A1—urine—prostate cancer	0.00277	0.0631	CbGeAlD
Mycophenolate mofetil—CYP3A4—Estrone—prostate cancer	0.00277	0.00583	CbGbCtD
Mycophenolate mofetil—ABCB1—Mitoxantrone—prostate cancer	0.00275	0.00578	CbGbCtD
Mycophenolate mofetil—UGT1A6—prostate gland—prostate cancer	0.00269	0.0612	CbGeAlD
Mycophenolate mofetil—CYP3A5—Etoposide—prostate cancer	0.00266	0.0056	CbGbCtD
Mycophenolate mofetil—ABCB1—Estradiol—prostate cancer	0.00265	0.00559	CbGbCtD
Mycophenolate mofetil—CYP2C8—Etoposide—prostate cancer	0.00256	0.00539	CbGbCtD
Mycophenolate mofetil—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00247	0.00519	CbGbCtD
Mycophenolate mofetil—CYP3A5—Docetaxel—prostate cancer	0.00243	0.00513	CbGbCtD
Mycophenolate mofetil—UGT1A7—renal system—prostate cancer	0.00236	0.0536	CbGeAlD
Mycophenolate mofetil—ABCB1—Prednisone—prostate cancer	0.00228	0.0048	CbGbCtD
Mycophenolate mofetil—UGT1A10—renal system—prostate cancer	0.00197	0.0448	CbGeAlD
Mycophenolate mofetil—CYP3A4—Conjugated Estrogens—prostate cancer	0.00181	0.00381	CbGbCtD
Mycophenolate mofetil—ABCB1—Etoposide—prostate cancer	0.00173	0.00365	CbGbCtD
Mycophenolate mofetil—CYP3A4—Mitoxantrone—prostate cancer	0.00165	0.00347	CbGbCtD
Mycophenolate mofetil—CYP3A4—Estradiol—prostate cancer	0.00159	0.00335	CbGbCtD
Mycophenolate mofetil—ABCB1—Docetaxel—prostate cancer	0.00158	0.00334	CbGbCtD
Mycophenolate mofetil—UGT1A8—renal system—prostate cancer	0.00156	0.0355	CbGeAlD
Mycophenolate mofetil—CYP3A4—Prednisone—prostate cancer	0.00137	0.00288	CbGbCtD
Mycophenolate mofetil—IMPDH2—prostate gland—prostate cancer	0.00129	0.0293	CbGeAlD
Mycophenolate mofetil—IMPDH1—prostate gland—prostate cancer	0.00128	0.0291	CbGeAlD
Mycophenolate mofetil—UGT1A6—testis—prostate cancer	0.00119	0.0269	CbGeAlD
Mycophenolate mofetil—ABCB1—Doxorubicin—prostate cancer	0.00118	0.00249	CbGbCtD
Mycophenolate mofetil—CES2—prostate gland—prostate cancer	0.00117	0.0266	CbGeAlD
Mycophenolate mofetil—UGT2B7—prostate gland—prostate cancer	0.00117	0.0266	CbGeAlD
Mycophenolate mofetil—IMPDH2—seminal vesicle—prostate cancer	0.00109	0.0248	CbGeAlD
Mycophenolate mofetil—IMPDH1—seminal vesicle—prostate cancer	0.00108	0.0246	CbGeAlD
Mycophenolate mofetil—CYP3A4—Etoposide—prostate cancer	0.00104	0.00219	CbGbCtD
Mycophenolate mofetil—UGT1A1—prostate gland—prostate cancer	0.000996	0.0226	CbGeAlD
Mycophenolate mofetil—CES2—seminal vesicle—prostate cancer	0.00099	0.0225	CbGeAlD
Mycophenolate mofetil—UGT1A9—renal system—prostate cancer	0.00099	0.0225	CbGeAlD
Mycophenolate mofetil—CES1—prostate gland—prostate cancer	0.000964	0.0219	CbGeAlD
Mycophenolate mofetil—CYP3A4—Docetaxel—prostate cancer	0.000949	0.002	CbGbCtD
Mycophenolate mofetil—IMPDH2—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000896	1	CbGdCrCtD
Mycophenolate mofetil—CYP3A4—urine—prostate cancer	0.000889	0.0202	CbGeAlD
Mycophenolate mofetil—IMPDH2—renal system—prostate cancer	0.000878	0.02	CbGeAlD
Mycophenolate mofetil—IMPDH1—renal system—prostate cancer	0.000873	0.0198	CbGeAlD
Mycophenolate mofetil—IMPDH2—urethra—prostate cancer	0.000863	0.0196	CbGeAlD
Mycophenolate mofetil—IMPDH1—urethra—prostate cancer	0.000857	0.0195	CbGeAlD
Mycophenolate mofetil—CES2—renal system—prostate cancer	0.000798	0.0181	CbGeAlD
Mycophenolate mofetil—UGT2B7—renal system—prostate cancer	0.000798	0.0181	CbGeAlD
Mycophenolate mofetil—CES2—urethra—prostate cancer	0.000784	0.0178	CbGeAlD
Mycophenolate mofetil—CYP3A4—Doxorubicin—prostate cancer	0.000708	0.00149	CbGbCtD
Mycophenolate mofetil—UGT1A1—renal system—prostate cancer	0.000679	0.0154	CbGeAlD
Mycophenolate mofetil—IMPDH2—bone marrow—prostate cancer	0.000664	0.0151	CbGeAlD
Mycophenolate mofetil—IMPDH1—bone marrow—prostate cancer	0.00066	0.015	CbGeAlD
Mycophenolate mofetil—ABCC2—prostate gland—prostate cancer	0.000628	0.0143	CbGeAlD
Mycophenolate mofetil—CES2—bone marrow—prostate cancer	0.000603	0.0137	CbGeAlD
Mycophenolate mofetil—IMPDH2—testis—prostate cancer	0.000568	0.0129	CbGeAlD
Mycophenolate mofetil—SLCO1B1—renal system—prostate cancer	0.000565	0.0128	CbGeAlD
Mycophenolate mofetil—IMPDH1—testis—prostate cancer	0.000564	0.0128	CbGeAlD
Mycophenolate mofetil—CES2—testis—prostate cancer	0.000516	0.0117	CbGeAlD
Mycophenolate mofetil—UGT2B7—testis—prostate cancer	0.000516	0.0117	CbGeAlD
Mycophenolate mofetil—ABCG2—prostate gland—prostate cancer	0.000458	0.0104	CbGeAlD
Mycophenolate mofetil—ABCC2—renal system—prostate cancer	0.000428	0.00973	CbGeAlD
Mycophenolate mofetil—CYP3A5—prostate gland—prostate cancer	0.000425	0.00967	CbGeAlD
Mycophenolate mofetil—CES1—testis—prostate cancer	0.000425	0.00966	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—prostate cancer	0.000411	0.00935	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—prostate cancer	0.000409	0.0093	CbGeAlD
Mycophenolate mofetil—ABCG2—seminal vesicle—prostate cancer	0.000387	0.00881	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—prostate cancer	0.000374	0.0085	CbGeAlD
Mycophenolate mofetil—CYP2C8—renal system—prostate cancer	0.000321	0.0073	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—prostate cancer	0.000308	0.007	CbGeAlD
Mycophenolate mofetil—ABCG2—urethra—prostate cancer	0.000307	0.00697	CbGeAlD
Mycophenolate mofetil—ALB—testis—prostate cancer	0.000295	0.00671	CbGeAlD
Mycophenolate mofetil—CYP3A5—renal system—prostate cancer	0.00029	0.00659	CbGeAlD
Mycophenolate mofetil—ABCC2—testis—prostate cancer	0.000277	0.00629	CbGeAlD
Mycophenolate mofetil—ABCG2—bone marrow—prostate cancer	0.000236	0.00537	CbGeAlD
Mycophenolate mofetil—ABCB1—prostate gland—prostate cancer	0.000226	0.00514	CbGeAlD
Mycophenolate mofetil—CYP3A4—renal system—prostate cancer	0.000217	0.00495	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—prostate cancer	0.000214	0.00487	CbGeAlD
Mycophenolate mofetil—CYP2C8—testis—prostate cancer	0.000208	0.00472	CbGeAlD
Mycophenolate mofetil—ABCG2—testis—prostate cancer	0.000202	0.00459	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—prostate cancer	0.000201	0.00456	CbGeAlD
Mycophenolate mofetil—ABCB1—seminal vesicle—prostate cancer	0.000191	0.00434	CbGeAlD
Mycophenolate mofetil—ABCB1—epithelium—prostate cancer	0.000166	0.00377	CbGeAlD
Mycophenolate mofetil—ABCB1—renal system—prostate cancer	0.000154	0.0035	CbGeAlD
Mycophenolate mofetil—ABCB1—urethra—prostate cancer	0.000151	0.00344	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—prostate cancer	0.000146	0.00333	CbGeAlD
Mycophenolate mofetil—ABCB1—bone marrow—prostate cancer	0.000116	0.00265	CbGeAlD
Mycophenolate mofetil—ABCB1—testis—prostate cancer	9.95e-05	0.00226	CbGeAlD
Mycophenolate mofetil—ABCB1—lymph node—prostate cancer	7.21e-05	0.00164	CbGeAlD
Mycophenolate mofetil—Hypotension—Capecitabine—prostate cancer	1.54e-05	9.45e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Docetaxel—prostate cancer	1.54e-05	9.44e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Prednisone—prostate cancer	1.53e-05	9.39e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Prednisone—prostate cancer	1.53e-05	9.39e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Docetaxel—prostate cancer	1.53e-05	9.38e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Prednisone—prostate cancer	1.53e-05	9.36e-05	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Doxorubicin—prostate cancer	1.53e-05	9.34e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.52e-05	9.33e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Docetaxel—prostate cancer	1.52e-05	9.31e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Docetaxel—prostate cancer	1.52e-05	9.28e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Prednisone—prostate cancer	1.52e-05	9.28e-05	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Epirubicin—prostate cancer	1.51e-05	9.26e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Etoposide—prostate cancer	1.51e-05	9.26e-05	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Epirubicin—prostate cancer	1.51e-05	9.24e-05	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Doxorubicin—prostate cancer	1.51e-05	9.22e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.5e-05	9.21e-05	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Epirubicin—prostate cancer	1.5e-05	9.2e-05	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Doxorubicin—prostate cancer	1.5e-05	9.19e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Docetaxel—prostate cancer	1.5e-05	9.19e-05	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Doxorubicin—prostate cancer	1.5e-05	9.17e-05	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Doxorubicin—prostate cancer	1.5e-05	9.17e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Capecitabine—prostate cancer	1.49e-05	9.14e-05	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Doxorubicin—prostate cancer	1.49e-05	9.13e-05	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Doxorubicin—prostate cancer	1.49e-05	9.1e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Capecitabine—prostate cancer	1.48e-05	9.08e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Docetaxel—prostate cancer	1.48e-05	9.08e-05	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Doxorubicin—prostate cancer	1.48e-05	9.06e-05	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Doxorubicin—prostate cancer	1.48e-05	9.03e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Docetaxel—prostate cancer	1.47e-05	9.01e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Etoposide—prostate cancer	1.47e-05	9.01e-05	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Doxorubicin—prostate cancer	1.47e-05	9.01e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Capecitabine—prostate cancer	1.47e-05	9.01e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Prednisone—prostate cancer	1.47e-05	9e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Prednisone—prostate cancer	1.47e-05	9e-05	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Epirubicin—prostate cancer	1.47e-05	8.99e-05	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Doxorubicin—prostate cancer	1.47e-05	8.99e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Mitoxantrone—prostate cancer	1.47e-05	8.97e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Prednisone—prostate cancer	1.46e-05	8.95e-05	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Epirubicin—prostate cancer	1.46e-05	8.93e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Docetaxel—prostate cancer	1.46e-05	8.93e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Docetaxel—prostate cancer	1.46e-05	8.93e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Capecitabine—prostate cancer	1.45e-05	8.9e-05	CcSEcCtD
Mycophenolate mofetil—Chills—Epirubicin—prostate cancer	1.45e-05	8.89e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Etoposide—prostate cancer	1.45e-05	8.89e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Prednisone—prostate cancer	1.45e-05	8.86e-05	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Epirubicin—prostate cancer	1.45e-05	8.85e-05	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Doxorubicin—prostate cancer	1.44e-05	8.84e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Prednisone—prostate cancer	1.44e-05	8.83e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Prednisone—prostate cancer	1.44e-05	8.79e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Capecitabine—prostate cancer	1.44e-05	8.79e-05	CcSEcCtD
Mycophenolate mofetil—Alopecia—Epirubicin—prostate cancer	1.43e-05	8.76e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Prednisone—prostate cancer	1.43e-05	8.75e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Capecitabine—prostate cancer	1.43e-05	8.73e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Prednisone—prostate cancer	1.42e-05	8.7e-05	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Epirubicin—prostate cancer	1.42e-05	8.68e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Capecitabine—prostate cancer	1.41e-05	8.64e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Capecitabine—prostate cancer	1.41e-05	8.64e-05	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Epirubicin—prostate cancer	1.41e-05	8.63e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Docetaxel—prostate cancer	1.41e-05	8.6e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Etoposide—prostate cancer	1.4e-05	8.6e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Prednisone—prostate cancer	1.4e-05	8.58e-05	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—prostate cancer	1.4e-05	8.57e-05	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—prostate cancer	1.4e-05	8.55e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Docetaxel—prostate cancer	1.39e-05	8.54e-05	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—prostate cancer	1.39e-05	8.51e-05	CcSEcCtD
Mycophenolate mofetil—Flatulence—Epirubicin—prostate cancer	1.39e-05	8.5e-05	CcSEcCtD
Mycophenolate mofetil—Tension—Epirubicin—prostate cancer	1.38e-05	8.47e-05	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Epirubicin—prostate cancer	1.38e-05	8.45e-05	CcSEcCtD
Mycophenolate mofetil—Nervousness—Epirubicin—prostate cancer	1.37e-05	8.38e-05	CcSEcCtD
Mycophenolate mofetil—Back pain—Epirubicin—prostate cancer	1.36e-05	8.35e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Capecitabine—prostate cancer	1.36e-05	8.33e-05	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—prostate cancer	1.36e-05	8.32e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Etoposide—prostate cancer	1.36e-05	8.31e-05	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Epirubicin—prostate cancer	1.35e-05	8.3e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Capecitabine—prostate cancer	1.35e-05	8.27e-05	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—prostate cancer	1.35e-05	8.27e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Docetaxel—prostate cancer	1.35e-05	8.25e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Docetaxel—prostate cancer	1.35e-05	8.25e-05	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—prostate cancer	1.34e-05	8.23e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Prednisone—prostate cancer	1.34e-05	8.2e-05	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—prostate cancer	1.34e-05	8.19e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisone—prostate cancer	1.33e-05	8.14e-05	CcSEcCtD
Mycophenolate mofetil—Alopecia—Doxorubicin—prostate cancer	1.32e-05	8.1e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisone—prostate cancer	1.32e-05	8.09e-05	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—prostate cancer	1.31e-05	8.04e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Capecitabine—prostate cancer	1.31e-05	8.03e-05	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Epirubicin—prostate cancer	1.31e-05	8.01e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Capecitabine—prostate cancer	1.31e-05	7.99e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Capecitabine—prostate cancer	1.31e-05	7.99e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Etoposide—prostate cancer	1.3e-05	7.99e-05	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—prostate cancer	1.3e-05	7.98e-05	CcSEcCtD
Mycophenolate mofetil—Anaemia—Epirubicin—prostate cancer	1.3e-05	7.98e-05	CcSEcCtD
Mycophenolate mofetil—Agitation—Epirubicin—prostate cancer	1.3e-05	7.93e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Prednisone—prostate cancer	1.29e-05	7.93e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Etoposide—prostate cancer	1.29e-05	7.92e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Etoposide—prostate cancer	1.29e-05	7.91e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Etoposide—prostate cancer	1.29e-05	7.87e-05	CcSEcCtD
Mycophenolate mofetil—Flatulence—Doxorubicin—prostate cancer	1.28e-05	7.87e-05	CcSEcCtD
Mycophenolate mofetil—Tension—Doxorubicin—prostate cancer	1.28e-05	7.83e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Prednisone—prostate cancer	1.28e-05	7.83e-05	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—prostate cancer	1.28e-05	7.82e-05	CcSEcCtD
Mycophenolate mofetil—Malaise—Epirubicin—prostate cancer	1.27e-05	7.78e-05	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—prostate cancer	1.27e-05	7.75e-05	CcSEcCtD
Mycophenolate mofetil—Vertigo—Epirubicin—prostate cancer	1.27e-05	7.75e-05	CcSEcCtD
Mycophenolate mofetil—Syncope—Epirubicin—prostate cancer	1.26e-05	7.74e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Epirubicin—prostate cancer	1.26e-05	7.72e-05	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—prostate cancer	1.26e-05	7.72e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Prednisone—prostate cancer	1.26e-05	7.7e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Docetaxel—prostate cancer	1.26e-05	7.69e-05	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—prostate cancer	1.25e-05	7.68e-05	CcSEcCtD
Mycophenolate mofetil—Palpitations—Epirubicin—prostate cancer	1.25e-05	7.63e-05	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Epirubicin—prostate cancer	1.24e-05	7.58e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Epirubicin—prostate cancer	1.23e-05	7.53e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Docetaxel—prostate cancer	1.22e-05	7.49e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Epirubicin—prostate cancer	1.22e-05	7.48e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Etoposide—prostate cancer	1.22e-05	7.46e-05	CcSEcCtD
Mycophenolate mofetil—Hypertension—Epirubicin—prostate cancer	1.22e-05	7.45e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Capecitabine—prostate cancer	1.22e-05	7.45e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisone—prostate cancer	1.21e-05	7.42e-05	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—prostate cancer	1.21e-05	7.41e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Docetaxel—prostate cancer	1.21e-05	7.39e-05	CcSEcCtD
Mycophenolate mofetil—Anaemia—Doxorubicin—prostate cancer	1.21e-05	7.38e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Prednisone—prostate cancer	1.2e-05	7.36e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Epirubicin—prostate cancer	1.2e-05	7.35e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Epirubicin—prostate cancer	1.2e-05	7.35e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Epirubicin—prostate cancer	1.2e-05	7.35e-05	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—prostate cancer	1.2e-05	7.34e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Epirubicin—prostate cancer	1.2e-05	7.32e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.19e-05	7.3e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Epirubicin—prostate cancer	1.19e-05	7.26e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Capecitabine—prostate cancer	1.18e-05	7.25e-05	CcSEcCtD
Mycophenolate mofetil—Malaise—Doxorubicin—prostate cancer	1.18e-05	7.2e-05	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Epirubicin—prostate cancer	1.17e-05	7.18e-05	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—prostate cancer	1.17e-05	7.17e-05	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—prostate cancer	1.17e-05	7.16e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisone—prostate cancer	1.17e-05	7.15e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Capecitabine—prostate cancer	1.17e-05	7.15e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—prostate cancer	1.17e-05	7.15e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Docetaxel—prostate cancer	1.17e-05	7.14e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Prednisone—prostate cancer	1.16e-05	7.12e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Prednisone—prostate cancer	1.16e-05	7.12e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Epirubicin—prostate cancer	1.16e-05	7.1e-05	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—prostate cancer	1.15e-05	7.06e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Epirubicin—prostate cancer	1.15e-05	7.04e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Epirubicin—prostate cancer	1.15e-05	7.04e-05	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—prostate cancer	1.15e-05	7.02e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Epirubicin—prostate cancer	1.14e-05	7e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—prostate cancer	1.14e-05	6.97e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Epirubicin—prostate cancer	1.13e-05	6.93e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—prostate cancer	1.13e-05	6.92e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Capecitabine—prostate cancer	1.13e-05	6.92e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Epirubicin—prostate cancer	1.13e-05	6.91e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Docetaxel—prostate cancer	1.13e-05	6.9e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Epirubicin—prostate cancer	1.13e-05	6.9e-05	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—prostate cancer	1.13e-05	6.89e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Epirubicin—prostate cancer	1.12e-05	6.87e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Epirubicin—prostate cancer	1.12e-05	6.84e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Epirubicin—prostate cancer	1.11e-05	6.81e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—prostate cancer	1.11e-05	6.8e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—prostate cancer	1.11e-05	6.8e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—prostate cancer	1.11e-05	6.8e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Doxorubicin—prostate cancer	1.11e-05	6.77e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.1e-05	6.75e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—prostate cancer	1.1e-05	6.72e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Epirubicin—prostate cancer	1.1e-05	6.71e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Capecitabine—prostate cancer	1.09e-05	6.68e-05	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Doxorubicin—prostate cancer	1.09e-05	6.65e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Docetaxel—prostate cancer	1.08e-05	6.64e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisone—prostate cancer	1.08e-05	6.63e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Docetaxel—prostate cancer	1.08e-05	6.58e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Epirubicin—prostate cancer	1.07e-05	6.58e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Docetaxel—prostate cancer	1.07e-05	6.58e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—prostate cancer	1.07e-05	6.57e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Docetaxel—prostate cancer	1.07e-05	6.54e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—prostate cancer	1.06e-05	6.52e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—prostate cancer	1.06e-05	6.52e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Doxorubicin—prostate cancer	1.06e-05	6.47e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Prednisone—prostate cancer	1.06e-05	6.46e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Capecitabine—prostate cancer	1.05e-05	6.43e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.05e-05	6.42e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—prostate cancer	1.05e-05	6.41e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—prostate cancer	1.04e-05	6.39e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—prostate cancer	1.04e-05	6.38e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Capecitabine—prostate cancer	1.04e-05	6.37e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Prednisone—prostate cancer	1.04e-05	6.37e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Epirubicin—prostate cancer	1.04e-05	6.37e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Capecitabine—prostate cancer	1.04e-05	6.37e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Doxorubicin—prostate cancer	1.04e-05	6.36e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Capecitabine—prostate cancer	1.03e-05	6.33e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—prostate cancer	1.03e-05	6.33e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Epirubicin—prostate cancer	1.03e-05	6.32e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—prostate cancer	1.03e-05	6.3e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Epirubicin—prostate cancer	1.03e-05	6.28e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Epirubicin—prostate cancer	1.02e-05	6.26e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Doxorubicin—prostate cancer	1.01e-05	6.21e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Docetaxel—prostate cancer	1.01e-05	6.2e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Epirubicin—prostate cancer	1.01e-05	6.2e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Prednisone—prostate cancer	1.01e-05	6.16e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Epirubicin—prostate cancer	1e-05	6.12e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—prostate cancer	9.94e-06	6.09e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Epirubicin—prostate cancer	9.93e-06	6.08e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Epirubicin—prostate cancer	9.84e-06	6.02e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Epirubicin—prostate cancer	9.84e-06	6.02e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Capecitabine—prostate cancer	9.81e-06	6e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisone—prostate cancer	9.73e-06	5.95e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.7e-06	5.94e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Doxorubicin—prostate cancer	9.63e-06	5.89e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—prostate cancer	9.56e-06	5.85e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—prostate cancer	9.49e-06	5.81e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Epirubicin—prostate cancer	9.48e-06	5.8e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—prostate cancer	9.46e-06	5.79e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Epirubicin—prostate cancer	9.41e-06	5.76e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—prostate cancer	9.37e-06	5.74e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Prednisone—prostate cancer	9.35e-06	5.72e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisone—prostate cancer	9.27e-06	5.68e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisone—prostate cancer	9.26e-06	5.67e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—prostate cancer	9.25e-06	5.66e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisone—prostate cancer	9.21e-06	5.64e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.19e-06	5.63e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Epirubicin—prostate cancer	9.14e-06	5.59e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—prostate cancer	9.1e-06	5.57e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—prostate cancer	9.1e-06	5.57e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Epirubicin—prostate cancer	9.09e-06	5.57e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Epirubicin—prostate cancer	9.09e-06	5.57e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—prostate cancer	8.77e-06	5.37e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisone—prostate cancer	8.74e-06	5.35e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—prostate cancer	8.7e-06	5.33e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Epirubicin—prostate cancer	8.47e-06	5.19e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Doxorubicin—prostate cancer	8.45e-06	5.18e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—prostate cancer	8.41e-06	5.15e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—prostate cancer	8.41e-06	5.15e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Epirubicin—prostate cancer	8.25e-06	5.05e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Epirubicin—prostate cancer	8.14e-06	4.98e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Epirubicin—prostate cancer	7.87e-06	4.82e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—prostate cancer	7.84e-06	4.8e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Doxorubicin—prostate cancer	7.64e-06	4.68e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Epirubicin—prostate cancer	7.61e-06	4.66e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Doxorubicin—prostate cancer	7.53e-06	4.61e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Epirubicin—prostate cancer	7.31e-06	4.48e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—prostate cancer	7.28e-06	4.46e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Epirubicin—prostate cancer	7.25e-06	4.44e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Epirubicin—prostate cancer	7.25e-06	4.44e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Epirubicin—prostate cancer	7.21e-06	4.41e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Doxorubicin—prostate cancer	7.04e-06	4.31e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Epirubicin—prostate cancer	6.83e-06	4.18e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Doxorubicin—prostate cancer	6.77e-06	4.14e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Doxorubicin—prostate cancer	6.71e-06	4.11e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—prostate cancer	6.7e-06	4.1e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Doxorubicin—prostate cancer	6.67e-06	4.08e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Doxorubicin—prostate cancer	6.32e-06	3.87e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—Metabolism—PRKACB—prostate cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CREBBP—prostate cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CREBBP—prostate cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NQO1—prostate cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NQO1—prostate cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP17A1—prostate cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CG—prostate cancer	1.28e-06	1.02e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TH—prostate cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL2—prostate cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TH—prostate cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—UCP3—prostate cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TCN2—prostate cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTA3—prostate cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PDHA1—prostate cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTEN—prostate cancer	1.26e-06	1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP3A4—prostate cancer	1.26e-06	1e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.26e-06	1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.26e-06	9.98e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP3A4—prostate cancer	1.26e-06	9.98e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—COMT—prostate cancer	1.25e-06	9.95e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.25e-06	9.93e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTP1—prostate cancer	1.25e-06	9.91e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP1B1—prostate cancer	1.24e-06	9.86e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP1B1—prostate cancer	1.23e-06	9.81e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CD—prostate cancer	1.23e-06	9.78e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CD—prostate cancer	1.23e-06	9.78e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ITPR1—prostate cancer	1.23e-06	9.75e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NCOA2—prostate cancer	1.22e-06	9.73e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—INS—prostate cancer	1.21e-06	9.65e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.21e-06	9.62e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.21e-06	9.62e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—EP300—prostate cancer	1.21e-06	9.58e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—AKT1—prostate cancer	1.2e-06	9.57e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GGT1—prostate cancer	1.2e-06	9.55e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GGT1—prostate cancer	1.2e-06	9.5e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CREBBP—prostate cancer	1.19e-06	9.45e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CG—prostate cancer	1.19e-06	9.44e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NCOA1—prostate cancer	1.18e-06	9.41e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NCOA1—prostate cancer	1.18e-06	9.36e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC5A5—prostate cancer	1.17e-06	9.28e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP19A1—prostate cancer	1.17e-06	9.27e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—NOS3—prostate cancer	1.16e-06	9.23e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NOS3—prostate cancer	1.16e-06	9.23e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP19A1—prostate cancer	1.16e-06	9.22e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTA4—prostate cancer	1.16e-06	9.22e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.16e-06	9.22e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TYMS—prostate cancer	1.16e-06	9.21e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTM1—prostate cancer	1.15e-06	9.1e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—EP300—prostate cancer	1.14e-06	9.07e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP2E1—prostate cancer	1.14e-06	9.07e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTEN—prostate cancer	1.14e-06	9.06e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTA2—prostate cancer	1.13e-06	8.98e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NQO1—prostate cancer	1.13e-06	8.96e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CD—prostate cancer	1.13e-06	8.96e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—RXRA—prostate cancer	1.13e-06	8.95e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—LPL—prostate cancer	1.13e-06	8.94e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—INS—prostate cancer	1.12e-06	8.93e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—RXRA—prostate cancer	1.12e-06	8.9e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.12e-06	8.87e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCG5—prostate cancer	1.12e-06	8.87e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TH—prostate cancer	1.11e-06	8.83e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SRC—prostate cancer	1.11e-06	8.82e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CREBBP—prostate cancer	1.1e-06	8.75e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP3A4—prostate cancer	1.1e-06	8.74e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.1e-06	8.71e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTA1—prostate cancer	1.09e-06	8.67e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.09e-06	8.66e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—EP300—prostate cancer	1.09e-06	8.64e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP1A1—prostate cancer	1.09e-06	8.63e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—COMT—prostate cancer	1.09e-06	8.62e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP1B1—prostate cancer	1.08e-06	8.59e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—prostate cancer	1.08e-06	8.59e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTP1—prostate cancer	1.08e-06	8.58e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—COMT—prostate cancer	1.08e-06	8.57e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.08e-06	8.57e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTO1—prostate cancer	1.08e-06	8.57e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NAT2—prostate cancer	1.08e-06	8.57e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ERCC2—prostate cancer	1.08e-06	8.56e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTP1—prostate cancer	1.07e-06	8.53e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CB—prostate cancer	1.07e-06	8.52e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CB—prostate cancer	1.07e-06	8.52e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—NOS3—prostate cancer	1.06e-06	8.46e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ITPR1—prostate cancer	1.06e-06	8.44e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTGS2—prostate cancer	1.06e-06	8.44e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTGS2—prostate cancer	1.06e-06	8.44e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ITPR1—prostate cancer	1.06e-06	8.4e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GGT1—prostate cancer	1.05e-06	8.32e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.05e-06	8.3e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CD—prostate cancer	1.04e-06	8.3e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.04e-06	8.26e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PLCB2—prostate cancer	1.03e-06	8.22e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—LRP2—prostate cancer	1.03e-06	8.22e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.03e-06	8.22e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NCOA1—prostate cancer	1.03e-06	8.2e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP19A1—prostate cancer	1.02e-06	8.08e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—P4HB—prostate cancer	1.01e-06	8.06e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—MTHFR—prostate cancer	1.01e-06	8.05e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TYMS—prostate cancer	1e-06	7.98e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TYMS—prostate cancer	9.99e-07	7.93e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PPARA—prostate cancer	9.94e-07	7.89e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTM1—prostate cancer	9.93e-07	7.89e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TGFB1—prostate cancer	9.92e-07	7.88e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTM1—prostate cancer	9.87e-07	7.84e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC22A1—prostate cancer	9.87e-07	7.84e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NOS3—prostate cancer	9.86e-07	7.83e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CB—prostate cancer	9.83e-07	7.81e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—RXRA—prostate cancer	9.82e-07	7.8e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—LPL—prostate cancer	9.74e-07	7.74e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS2—prostate cancer	9.74e-07	7.74e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—LPL—prostate cancer	9.69e-07	7.7e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SULT2A1—prostate cancer	9.62e-07	7.64e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—MED12—prostate cancer	9.46e-07	7.52e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—COMT—prostate cancer	9.46e-07	7.51e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTP1—prostate cancer	9.41e-07	7.48e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP1A1—prostate cancer	9.41e-07	7.48e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GNG5—prostate cancer	9.39e-07	7.46e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP1A1—prostate cancer	9.36e-07	7.43e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CAV1—prostate cancer	9.34e-07	7.42e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ERCC2—prostate cancer	9.33e-07	7.41e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ERCC2—prostate cancer	9.28e-07	7.37e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTEN—prostate cancer	9.27e-07	7.36e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTEN—prostate cancer	9.27e-07	7.36e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ITPR1—prostate cancer	9.26e-07	7.36e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KRAS—prostate cancer	9.19e-07	7.3e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CB—prostate cancer	9.1e-07	7.23e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NCOA3—prostate cancer	9.04e-07	7.18e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS2—prostate cancer	9.02e-07	7.16e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CA—prostate cancer	8.92e-07	7.08e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—EP300—prostate cancer	8.84e-07	7.02e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—EP300—prostate cancer	8.84e-07	7.02e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—MTHFR—prostate cancer	8.77e-07	6.97e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TYMS—prostate cancer	8.75e-07	6.95e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—MTHFR—prostate cancer	8.72e-07	6.93e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTM1—prostate cancer	8.65e-07	6.87e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HPGDS—prostate cancer	8.63e-07	6.85e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PPARA—prostate cancer	8.61e-07	6.84e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2C19—prostate cancer	8.57e-07	6.81e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPARA—prostate cancer	8.56e-07	6.8e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CG—prostate cancer	8.51e-07	6.76e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTEN—prostate cancer	8.49e-07	6.75e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—LPL—prostate cancer	8.49e-07	6.74e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CA—prostate cancer	8.44e-07	6.71e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ACHE—prostate cancer	8.37e-07	6.65e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTT1—prostate cancer	8.37e-07	6.65e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2A6—prostate cancer	8.27e-07	6.57e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP1A1—prostate cancer	8.2e-07	6.51e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—prostate cancer	8.17e-07	6.49e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ERCC2—prostate cancer	8.13e-07	6.46e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—EP300—prostate cancer	8.1e-07	6.43e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CAV1—prostate cancer	8.09e-07	6.43e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—INS—prostate cancer	8.06e-07	6.4e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CA—prostate cancer	8.05e-07	6.39e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CAV1—prostate cancer	8.05e-07	6.39e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKR1C3—prostate cancer	8.04e-07	6.39e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PRKACB—prostate cancer	8e-07	6.36e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.92e-07	6.29e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CREBBP—prostate cancer	7.89e-07	6.27e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTEN—prostate cancer	7.86e-07	6.25e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.73e-07	6.14e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.69e-07	6.11e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—MTHFR—prostate cancer	7.64e-07	6.07e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NCOA2—prostate cancer	7.55e-07	5.99e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—EP300—prostate cancer	7.5e-07	5.96e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PPARA—prostate cancer	7.5e-07	5.96e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CD—prostate cancer	7.48e-07	5.94e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CG—prostate cancer	7.37e-07	5.86e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CG—prostate cancer	7.33e-07	5.82e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKT1—prostate cancer	7.29e-07	5.79e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC5A5—prostate cancer	7.2e-07	5.72e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NOS3—prostate cancer	7.06e-07	5.61e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CAV1—prostate cancer	7.05e-07	5.6e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2E1—prostate cancer	7.03e-07	5.59e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—INS—prostate cancer	6.98e-07	5.54e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NQO1—prostate cancer	6.95e-07	5.52e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—INS—prostate cancer	6.94e-07	5.51e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—AKT1—prostate cancer	6.9e-07	5.48e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TH—prostate cancer	6.85e-07	5.44e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CREBBP—prostate cancer	6.83e-07	5.43e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CREBBP—prostate cancer	6.8e-07	5.4e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.67e-07	5.29e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKT1—prostate cancer	6.57e-07	5.22e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CA—prostate cancer	6.54e-07	5.19e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CA—prostate cancer	6.54e-07	5.19e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CB—prostate cancer	6.52e-07	5.18e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CD—prostate cancer	6.48e-07	5.15e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS2—prostate cancer	6.46e-07	5.13e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GGT1—prostate cancer	6.46e-07	5.13e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CD—prostate cancer	6.44e-07	5.12e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CG—prostate cancer	6.42e-07	5.1e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NCOA1—prostate cancer	6.36e-07	5.05e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP19A1—prostate cancer	6.27e-07	4.98e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NOS3—prostate cancer	6.12e-07	4.86e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NOS3—prostate cancer	6.08e-07	4.83e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—INS—prostate cancer	6.08e-07	4.83e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—RXRA—prostate cancer	6.05e-07	4.8e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CA—prostate cancer	5.99e-07	4.76e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CREBBP—prostate cancer	5.95e-07	4.73e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—COMT—prostate cancer	5.83e-07	4.63e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTP1—prostate cancer	5.8e-07	4.61e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ITPR1—prostate cancer	5.71e-07	4.53e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CB—prostate cancer	5.65e-07	4.49e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CD—prostate cancer	5.65e-07	4.48e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTEN—prostate cancer	5.64e-07	4.48e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CB—prostate cancer	5.62e-07	4.46e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS2—prostate cancer	5.6e-07	4.45e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS2—prostate cancer	5.56e-07	4.42e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CA—prostate cancer	5.55e-07	4.41e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TYMS—prostate cancer	5.39e-07	4.28e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—EP300—prostate cancer	5.37e-07	4.27e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKT1—prostate cancer	5.34e-07	4.24e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKT1—prostate cancer	5.34e-07	4.24e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NOS3—prostate cancer	5.33e-07	4.23e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTM1—prostate cancer	5.33e-07	4.23e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—LPL—prostate cancer	5.23e-07	4.15e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.05e-07	4.01e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ERCC2—prostate cancer	5.01e-07	3.98e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CB—prostate cancer	4.92e-07	3.91e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKT1—prostate cancer	4.9e-07	3.89e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTEN—prostate cancer	4.88e-07	3.88e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS2—prostate cancer	4.88e-07	3.87e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTEN—prostate cancer	4.85e-07	3.86e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—MTHFR—prostate cancer	4.71e-07	3.74e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—EP300—prostate cancer	4.65e-07	3.7e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—EP300—prostate cancer	4.63e-07	3.68e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPARA—prostate cancer	4.62e-07	3.67e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKT1—prostate cancer	4.53e-07	3.6e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CAV1—prostate cancer	4.34e-07	3.45e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTEN—prostate cancer	4.25e-07	3.38e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—EP300—prostate cancer	4.06e-07	3.22e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CA—prostate cancer	3.98e-07	3.16e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.96e-07	3.14e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—INS—prostate cancer	3.75e-07	2.98e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CREBBP—prostate cancer	3.67e-07	2.91e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.48e-07	2.76e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.44e-07	2.74e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CA—prostate cancer	3.42e-07	2.72e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NOS3—prostate cancer	3.28e-07	2.61e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKT1—prostate cancer	3.25e-07	2.58e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.03e-07	2.41e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS2—prostate cancer	3e-07	2.39e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CA—prostate cancer	3e-07	2.38e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKT1—prostate cancer	2.81e-07	2.23e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKT1—prostate cancer	2.8e-07	2.22e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTEN—prostate cancer	2.62e-07	2.08e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—EP300—prostate cancer	2.5e-07	1.98e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKT1—prostate cancer	2.45e-07	1.95e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.85e-07	1.47e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKT1—prostate cancer	1.51e-07	1.2e-06	CbGpPWpGaD
